Compare GNLX & ZIONP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GNLX | ZIONP |
|---|---|---|
| Founded | 2001 | N/A |
| Country | United States | United States |
| Employees | N/A | 9195 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 113.6M | N/A |
| IPO Year | 2022 | N/A |
| Metric | GNLX | ZIONP |
|---|---|---|
| Price | $2.49 | $19.37 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $19.80 | N/A |
| AVG Volume (30 Days) | ★ 129.7K | 6.8K |
| Earning Date | 03-19-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 9.47 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $8,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.99 | $18.90 |
| 52 Week High | $8.54 | $24.40 |
| Indicator | GNLX | ZIONP |
|---|---|---|
| Relative Strength Index (RSI) | 40.20 | 48.46 |
| Support Level | $2.35 | N/A |
| Resistance Level | $2.86 | $19.43 |
| Average True Range (ATR) | 0.14 | 0.18 |
| MACD | -0.02 | 0.04 |
| Stochastic Oscillator | 28.13 | 88.68 |
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.
Zions Bancorp is a US regional bank with around $90 billion in total assets as of Sept. 30, 2025. Headquartered in Salt Lake City, Utah, Zions' branch network is in the Western and Southwestern United States and includes seven affiliate banks in these markets. The bank has a heavy focus on small and midsize commercial banking.